Upstream regulators inhibited at the same early time point include CSF2, which supports M1 macrophage polarization [53], and CD38, whose loss attenuates glioma progression [54,55] (Additional file 1: Table S6). The gene discussed is CSF2; the disease is central nervous system cancer.